×
ADVERTISEMENT

nogapendekin alfa inbakicept-pmln

Anktiva Approved for BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer

The FDA approved nogapendekin Anktiva with Bacillus Calmette-Guérin for adult patients with BCG-unresponsive ...

APRIL 24, 2024

Load more